{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:29:56Z","timestamp":1787992196312,"version":"build-2784847793"},"reference-count":272,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a disease characterized by dysregulation and hyperreactivity of the immune response at various levels, including hyperactivation of effector cell subtypes, autoantibodies production, immune complex formation, and deposition in tissues. The consequences of hyperreactivity to the self are systemic and local inflammation and tissue damage in multiple organs. Lupus nephritis (LN) is one of the most worrying manifestations of SLE, and most patients have this involvement at some point in the course of the disease. Among the effector cells involved, the Th17, a subtype of T helper cells (CD4+), has shown significant hyperactivation and participates in kidney damage and many other organs. Th17 cells have IL-17A and IL-17F as main cytokines with receptors expressed in most renal cells, being involved in the activation of many proinflammatory and profibrotic pathways. The Th17\/IL-17 axis promotes and maintains repetitive tissue damage and maladaptive repair; leading to fibrosis, loss of organ architecture and function. In the podocytes, the Th17\/IL-17 axis effects include changes of the cytoskeleton with increased motility, decreased expression of health proteins, increased oxidative stress, and activation of the inflammasome and caspases resulting in podocytes apoptosis. In renal tubular epithelial cells, the Th17\/IL-17 axis promotes the activation of profibrotic pathways such as increased TGF-\u03b2 expression and epithelial-mesenchymal transition (EMT) with consequent increase of extracellular matrix proteins. In addition, the IL-17 promotes a proinflammatory environment by stimulating the synthesis of inflammatory cytokines by intrinsic renal cells and immune cells, and the synthesis of growth factors and chemokines, which together result in granulopoiesis\/myelopoiesis, and further recruitment of immune cells to the kidney. The purpose of this work is to present the prognostic and immunopathologic role of the Th17\/IL-17 axis in Kidney diseases, with a special focus on LN, including its exploration as a potential immunotherapeutic target in this complication.<\/jats:p>","DOI":"10.3389\/fmed.2021.654912","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T08:53:56Z","timestamp":1630745636000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":83,"title":["The Th17\/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis"],"prefix":"10.3389","volume":"8","author":[{"given":"Feliciano Chanana","family":"Paquissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Abensur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.4049\/jimmunol.1701179","article-title":"Relative contributions of B cells and dendritic cells from lupus-prone mice to CD4 T cell polarization","volume":"200","author":"Choi","year":"2018","journal-title":"J Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"12061","DOI":"10.1073\/pnas.0905441106","article-title":"Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus","volume":"106","author":"Kono","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci Transl Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar2964","article-title":"Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus","volume":"12","author":"Shah","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity."},{"key":"B9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/art.38239","article-title":"The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cmi.2015.89","article-title":"The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"Cell Mol Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fimmu.2019.00391","article-title":"Altered Th17\/Treg ratio in peripheral blood of systemic lupus erythematosus but not primary antiphospholipid syndrome","volume":"10","author":"\u00c1lvarez-Rodr\u00edguez","year":"2019","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cellimm.2010.05.004","article-title":"Frequency and functional activity of Th17, Tc17 and other T-cell subsets in systemic lupus erythematosus","volume":"264","author":"Henriques","year":"2010","journal-title":"Cell Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fimmu.2015.00610","article-title":"Disturbed T cell signaling and altered Th17 and regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus","volume":"6","author":"Rother","year":"2015","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.3899\/jrheum.100293","article-title":"The relation of interleukin 17 (IL-17) and IL-23 to Th1\/Th2 cytokines and disease activity in systemic lupus erythematosus","volume":"37","author":"Mok","year":"2010","journal-title":"J Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s10067-010-1510-7","article-title":"The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients","volume":"29","author":"Ma","year":"2010","journal-title":"Clin Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.clim.2015.01.010","article-title":"Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases","volume":"157","author":"Ichinose","year":"2015","journal-title":"Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar4277","article-title":"Clinical associations of serum interleukin-17 in systemic lupus erythematosus","volume":"15","author":"Vincent","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2230.2010.03996.x","article-title":"Expression of interleukin-17 is correlated with interferon-\u03b1 expression in cutaneous lesions of lupus erythematosus","volume":"36","author":"Oh","year":"2011","journal-title":"Clin Exp Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jdermsci.2012.10.004","article-title":"Co-culture of healthy human keratinocytes and T-cells promotes keratinocyte chemokine production and ROR\u03b3t-positive IL-17 producing T-cell populations","volume":"69","author":"Peters","year":"2013","journal-title":"J Dermatol Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.clim.2018.08.005","article-title":"Th1\/17 cells, a subset of Th17 cells, are expanded in patients with active systemic lupus erythematosus","volume":"195","author":"Tsanaktsi","year":"2018","journal-title":"Clin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1681\/ASN.2008050556","article-title":"The IL-23\/Th17 axis contributes to renal injury in experimental glomerulonephritis","volume":"20","author":"Paust","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.immuni.2012.08.014","article-title":"Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis","volume":"37","author":"Pisitkun","year":"2012","journal-title":"Immunity."},{"key":"B25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1681\/ASN.2010050536","article-title":"The emergence of TH17 cells as effectors of renal injury","volume":"22","author":"Kitching","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ki.2010.102","article-title":"The Th17 immune response in renal inflammation","volume":"77","author":"Turner","year":"2010","journal-title":"Kidney Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scand J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.autrev.2018.08.006","article-title":"Th17 cells in renal inflammation and autoimmunity","volume":"18","author":"Dolff","year":"2019","journal-title":"Autoimmun Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrneph.2017.112","article-title":"T helper type 17 cells in immune-mediated glomerular disease","volume":"13","author":"Krebs","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"F244","DOI":"10.1152\/ajprenal.00113.2011","article-title":"IL-17A stimulates granulocyte colony-stimulating factor production via ERK1\/2 but not p38 or JNK in human renal proximal tubular epithelial cells","volume":"302","author":"Hirai","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"F779","DOI":"10.1152\/ajprenal.00198.2009","article-title":"IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1\/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta","volume":"298","author":"Iyoda","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1681\/ASN.2017090949","article-title":"IL-17C\/IL-17 receptor E signaling in CD4 T cells promotes T17 cell-driven glomerular inflammation","volume":"29","author":"Krohn","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1159\/000430197","article-title":"Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment","volume":"36","author":"Yuan","year":"2015","journal-title":"Cell Physiol Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1755-7682-1-19","article-title":"Expression of interleukin-17RC protein in normal human tissues","volume":"1","author":"Ge","year":"2008","journal-title":"Int Arch Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","article-title":"IL-17A produced by both \u03b3\u03b4 T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction","volume":"235","author":"Peng","year":"2015","journal-title":"J Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"F385","DOI":"10.1152\/ajprenal.00462.2016","article-title":"IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion: compensatory role of natural killer cells in athymic rats","volume":"312","author":"Mehrotra","year":"2017","journal-title":"Am J Physiol Renal Physiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3389\/fimmu.2018.02385","article-title":"Complement C3 produced by macrophages promotes renal fibrosis via IL-17A secretion","volume":"9","author":"Liu","year":"2018","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"109741","DOI":"10.1016\/j.biopha.2019.109741","article-title":"Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways","volume":"123","author":"Weng","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.humimm.2015.01.027","article-title":"Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort","volume":"76","author":"Coto","year":"2015","journal-title":"Hum Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.4049\/jimmunol.0802948","article-title":"Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway","volume":"182","author":"Jacob","year":"2009","journal-title":"J Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12865-015-0070-7","article-title":"IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment","volume":"16","author":"Zickert","year":"2015","journal-title":"BMC Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/0961203312457718","article-title":"The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis","volume":"21","author":"Chen","year":"2012","journal-title":"Lupus."},{"key":"B44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/03009742.2014.962080","article-title":"Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis","volume":"44","author":"Xia","year":"2015","journal-title":"Scand J Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.imlet.2019.04.002","article-title":"Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients","volume":"210","author":"Dedong","year":"2019","journal-title":"Immunol Lett."},{"key":"B46","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1681\/ASN.2010040435","article-title":"The Th17-defining transcription factor ROR\u03b3t promotes glomerulonephritis","volume":"22","author":"Steinmetz","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/cei.12905","article-title":"ROR\u03b3t expression in T promotes systemic lupus erythematosus via IL-17 secretion, alteration of T phenotype and suppression of Th2 responses","volume":"188","author":"Kluger","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.3892\/etm.2019.7168","article-title":"Analysis of expression levels of IL-17 and IL-34 and influencing factors for prognosis in patients with lupus nephritis","volume":"17","author":"Cheng","year":"2019","journal-title":"Exp Ther Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00467-013-2695-1","article-title":"Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis","volume":"29","author":"Yazici","year":"2014","journal-title":"Pediatr Nephrol."},{"key":"B50","first-page":"67","article-title":"Induction therapy downregulates the expression of Th17\/Tfh cytokines in patients with active lupus nephritis","volume":"7","author":"Wang","year":"2018","journal-title":"Am J Clin Exp Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2009.04031.x","article-title":"Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis","volume":"159","author":"Wang","year":"2010","journal-title":"Clin Exp Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cyto.2015.05.007","article-title":"The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis","volume":"76","author":"Abdel Galil","year":"2015","journal-title":"Cytokine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejr.2017.01.005","article-title":"Expression of T helper 17 cells and interleukin 17 in lupus nephritis patients","volume":"39","author":"Saber","year":"2017","journal-title":"Egypt Rheumatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"204","DOI":"10.15171\/jrip.2019.38","article-title":"Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis","volume":"8","author":"Nakhjavani","year":"2019","journal-title":"J Renal Injury Prevent."},{"key":"B55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pathophys.2014.12.003","article-title":"Analysis of urinary TGF-\u03b21, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis","volume":"22","author":"Susianti","year":"2015","journal-title":"Pathophysiology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4927530","DOI":"10.1155\/2016\/4927530","article-title":"Serum cytokines Th1, Th2, and Th17 expression profiling in active lupus nephritis-IV: from a Southern Chinese Han population","volume":"2016","author":"Sigdel","year":"2016","journal-title":"Mediators Inflamm."},{"key":"B57","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00296-010-1771-0","article-title":"Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis","volume":"32","author":"Xing","year":"2012","journal-title":"Rheumatol Int."},{"key":"B58","first-page":"543","article-title":"IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients","volume":"116","author":"Dong","year":"2003","journal-title":"Chin Med J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e5738","DOI":"10.1590\/1414-431x20175738","article-title":"Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study","volume":"50","author":"Cavalcanti","year":"2017","journal-title":"Braz J Med Biol Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.4049\/jimmunol.1400044","article-title":"Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis","volume":"193","author":"Kshirsagar","year":"2014","journal-title":"J Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.6061\/clinics\/2015(05)01","article-title":"Serum interleukin-17 levels are associated with nephritis in childhood-onset systemic lupus erythematosus","volume":"70","author":"Peli\u00e7ari K de","year":"2015","journal-title":"Clinics."},{"key":"B62","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/1756-185X.12393","article-title":"Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis","volume":"19","author":"AlFadhli","year":"2016","journal-title":"Int J Rheum Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cei.13196","article-title":"Facilitated expansion of Th17 cells in lupus nephritis patients","volume":"194","author":"Jakiela","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10875-011-9637-0","article-title":"Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis","volume":"32","author":"Edelbauer","year":"2012","journal-title":"J Clin Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0961203320922305","article-title":"Association of interleukin-17A gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multi-centre study","volume":"29","author":"Elkoumi","year":"2020","journal-title":"Lupus."},{"key":"B66","first-page":"113","article-title":"Expression of T helper 17 and regulatory T cell cytokines and molecules in glomerulonephritis class IV systemic lupus erythematosus","volume":"10","author":"Rastin","year":"2016","journal-title":"Iran J Kidney Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.immuni.2020.04.015","article-title":"Plasmacytoid dendritic cells and type i interferon promote extrafollicular B cell responses to extracellular self-DNA","volume":"52","author":"Soni","year":"2020","journal-title":"Immunity."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","article-title":"Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin","volume":"67","author":"Wang","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jaut.2010.05.004","article-title":"TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy","volume":"35","author":"Summers","year":"2010","journal-title":"J Autoimmun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3899\/jrheum.151386","article-title":"Cell membrane-bound TLR2 and TLR4: potential predictors of active systemic lupus erythematosus and lupus nephritis","volume":"43","author":"P\u00e9rez-Ferro","year":"2016","journal-title":"J Rheumatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/annrheumdis-2018-213615","article-title":"TLR4CXCR4 plasma cells drive nephritis development in systemic lupus erythematosus","volume":"77","author":"Ma","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1681\/ASN.2011111077","article-title":"Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4","volume":"23","author":"Allam","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.immuni.2008.06.009","article-title":"T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells","volume":"29","author":"Herlands","year":"2008","journal-title":"Immunity."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1681\/ASN.2006101162","article-title":"Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus","volume":"18","author":"Pawar","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.3389\/fimmu.2018.01957","article-title":"Up-regulation of TLR7-mediated IFN-\u03b1 production by plasmacytoid dendritic cells in patients with systemic lupus erythematosus","volume":"9","author":"Sakata","year":"2018","journal-title":"Front Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/art.39417","article-title":"Circulating apoptotic microparticles in systemic lupus erythematosus patients drive the activation of dendritic cell subsets and prime neutrophils for NETosis","volume":"68","author":"Dieker","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev-immunol-020711-074929","article-title":"Molecular control of steady-state dendritic cell maturation and immune homeostasis","volume":"31","author":"Hammer","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","article-title":"Human inflammatory dendritic cells induce Th17 cell differentiation","volume":"38","author":"Segura","year":"2013","journal-title":"Immunity."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.celrep.2017.05.052","article-title":"Cellular stress in the context of an inflammatory environment supports TGF-\u03b2-independent T helper-17 differentiation","volume":"19","author":"Brucklacher-Waldert","year":"2017","journal-title":"Cell Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity."},{"key":"B82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-065X.2009.00773.x","article-title":"Molecular mechanisms of T-cell receptor and costimulatory molecule ligation\/blockade in autoimmune disease therapy","volume":"229","author":"Podojil","year":"2009","journal-title":"Immunol Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2016.00022","article-title":"Expression of TLR-7, MyD88, NF-kB, and INF-\u03b1 in B lymphocytes of Mayan women with systemic lupus erythematosus in Mexico","volume":"7","author":"Pacheco","year":"2016","journal-title":"Front Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/rheumatology\/keaa176","article-title":"Interleukin-23 drives expansion of Thelper 17 cells through epigenetic regulation by signal transducer and activators of transcription 3 in lupus patients","volume":"59","author":"Lee","year":"2020","journal-title":"Rheumatology."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10067-019-04467-8","article-title":"Upregulated expression of STAT3\/IL-17 in patients with systemic lupus erythematosus","volume":"38","author":"Chen","year":"2019","journal-title":"Clin Rheumatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1681\/ASN.2015101077","article-title":"IL-17F promotes tissue injury in autoimmune kidney diseases","volume":"27","author":"Riedel","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.kint.2020.01.015","article-title":"IL-17C has a pathogenic role in kidney ischemia\/reperfusion injury","volume":"97","author":"Wang","year":"2020","journal-title":"Kidney Int."},{"key":"B88","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pathol.2017.01.003","article-title":"The role of interleukin-17A in the pathogenesis of kidney diseases","volume":"49","author":"Cortvrindt","year":"2017","journal-title":"Pathology."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2121849","DOI":"10.1155\/2019\/2121849","article-title":"Mesangial cells exhibit features of antigen-presenting cells and activate CD4+ T cell responses","volume":"2019","author":"Yu","year":"2019","journal-title":"J Immunol Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/ndt\/gfq058","article-title":"Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis","volume":"25","author":"Machida","year":"2010","journal-title":"Nephrol Dial Transplant."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1172\/JCI31008","article-title":"TLR4 activation mediates kidney ischemia\/reperfusion injury","volume":"117","author":"Wu","year":"2007","journal-title":"J Clin Invest."},{"key":"B92","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fimmu.2017.00122","article-title":"Innate immune activity in glomerular podocytes","volume":"8","author":"Xia","year":"2017","journal-title":"Front Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/path.5508","article-title":"Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease","volume":"252","author":"Li","year":"2020","journal-title":"J Pathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"8587923","DOI":"10.1155\/2020\/8587923","article-title":"LPS-treated podocytes polarize naive CD4 T cells into Th17 and Treg cells","volume":"2020","author":"Yuan","year":"2020","journal-title":"Biomed Res Int."},{"key":"B95","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/ki.2011.348","article-title":"Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction","volume":"81","author":"Pindjakova","year":"2012","journal-title":"Kidney Int."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/art.39665","article-title":"Calcium\/calmodulin-dependent kinase IV facilitates the recruitment of interleukin-17-producing cells to target organs through the CCR6\/CCL20 axis in Th17 cell-driven inflammatory diseases","volume":"68","author":"Koga","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.4049\/jimmunol.1201785","article-title":"Calcium\/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus","volume":"189","author":"Koga","year":"2012","journal-title":"J Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"eaba4163","DOI":"10.1126\/sciimmunol.aba4163","article-title":"Pathogen-induced tissue-resident memory T17 (T17) cells amplify autoimmune kidney disease","volume":"5","author":"Krebs","year":"2020","journal-title":"Sci Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity."},{"key":"B100","doi-asserted-by":"publisher","first-page":"8450947","DOI":"10.1155\/2019\/8450947","article-title":"Dysregulated T cell activation and aberrant cytokine expression profile in systemic lupus erythematosus","volume":"2019","author":"Zhou","year":"2019","journal-title":"Mediators Inflamm."},{"key":"B101","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity."},{"key":"B102","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature."},{"key":"B103","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B104","doi-asserted-by":"publisher","first-page":"108267","DOI":"10.1016\/j.clim.2019.108267","article-title":"Reprograming of peripheral Foxp3 regulatory T cell towards Th17-like cell in patients with active systemic lupus erythematosus","volume":"209","author":"Jiang","year":"2019","journal-title":"Clin Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1365-2249.2011.04424.x","article-title":"Interleukin-10 receptor expression and signalling were down-regulated in CD4+ T cells of lupus nephritis patients","volume":"165","author":"Cui","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","article-title":"Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells","volume":"186","author":"Carter","year":"2011","journal-title":"J Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3389\/fimmu.2016.00512","article-title":"CD16 monocyte subset was enriched and functionally exacerbated in driving T-cell activation and B-cell response in systemic lupus erythematosus","volume":"7","author":"Zhu","year":"2016","journal-title":"Front Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2011.12.004","article-title":"Phenotype and function of dendritic cells of patients with systemic lupus erythematosus","volume":"143","author":"Crisp\u00edn","year":"2012","journal-title":"Clin Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e17495","DOI":"10.1371\/journal.pone.0017495","article-title":"Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells","volume":"6","author":"Sule","year":"2011","journal-title":"PLoS ONE."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/ar3251","article-title":"Abnormalities of T cell signaling in systemic lupus erythematosus","volume":"13","author":"Moulton","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T cell signaling and subsets in systemic lupus erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front Immunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/art.39720","article-title":"Epigenetic reprogramming in naive CD4+ T cells favoring T cell activation and non-Th1 effector T cell immune response as an early event in lupus flares","volume":"68","author":"Coit","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaut.2013.04.003","article-title":"Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in na\u00efve CD4+ T cells from lupus patients","volume":"43","author":"Coit","year":"2013","journal-title":"J Autoimmun."},{"key":"B116","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1128\/AEM.02676-14","article-title":"Dynamics of gut microbiota in autoimmune lupus","volume":"80","author":"Zhang","year":"2014","journal-title":"Appl Environ Microbiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","article-title":"Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal","volume":"78","author":"Azzouz","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"24072","DOI":"10.1038\/srep24072","article-title":"Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients","volume":"6","author":"L\u00f3pez","year":"2016","journal-title":"Sci Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.immuni.2016.10.020","article-title":"Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney","volume":"45","author":"Krebs","year":"2016","journal-title":"Immunity."},{"key":"B120","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fimmu.2017.00348","article-title":"Basophil activation-dependent autoantibody and interleukin-17 production exacerbate systemic lupus erythematosus","volume":"8","author":"Pan","year":"2017","journal-title":"Front Immunol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fimmu.2020.00233","article-title":"Reduced Let-7f in bone marrow-derived mesenchymal stem cells triggers Treg\/Th17 imbalance in patients with systemic lupus erythematosus","volume":"11","author":"Geng","year":"2020","journal-title":"Front Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1681\/ASN.2006111237","article-title":"Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice","volume":"18","author":"Panzer","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e0178352","DOI":"10.1371\/journal.pone.0178352","article-title":"CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One."},{"key":"B124","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4049\/jimmunol.180.1.214","article-title":"Human T cells that are able to produce IL-17 express the chemokine receptor CCR6","volume":"180","author":"Singh","year":"2008","journal-title":"J Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.4049\/jimmunol.0802626","article-title":"CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis","volume":"183","author":"Steinmetz","year":"2009","journal-title":"J Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1681\/ASN.2009070741","article-title":"CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis","volume":"21","author":"Turner","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3389\/fimmu.2018.02113","article-title":"Calcium\/calmodulin kinase IV controls the function of both T cells and kidney resident cells","volume":"9","author":"Ferretti","year":"2018","journal-title":"Front Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cei.12579","article-title":"CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis","volume":"180","author":"Petrovic-Djergovic","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cyto.2013.03.016","article-title":"Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis","volume":"62","author":"Kanapathippillai","year":"2013","journal-title":"Cytokine."},{"key":"B130","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.matbio.2017.12.002","article-title":"Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney","author":"Nastase","year":"2018","journal-title":"Matrix Biol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.immuni.2015.02.015","article-title":"Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus","volume":"42","author":"Teichmann","year":"2015","journal-title":"Immunity."},{"key":"B132","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.4049\/jimmunol.0800758","article-title":"ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus","volume":"182","author":"Odegard","year":"2009","journal-title":"J Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-017-1258-4","article-title":"Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients","volume":"19","author":"Shi","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"T(H)-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"F913","DOI":"10.1152\/ajprenal.00093.2019","article-title":"Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation","volume":"317","author":"May","year":"2019","journal-title":"Am J Physiol Renal Physiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1159\/000430296","article-title":"Induction of C-Mip by IL-17 plays an important role in adriamycin-induced podocyte damage","volume":"36","author":"Liu","year":"2015","journal-title":"Cell Physiol Biochem."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.kint.2016.07.016","article-title":"Repression of CMIP transcription by WT1 is relevant to podocyte health","volume":"90","author":"Moktefi","year":"2016","journal-title":"Kidney Int."},{"key":"B139","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.3892\/mmr.2017.7156","article-title":"c-Maf inducing protein inhibits cofilin-1 activity and alters podocyte cytoskeleton organization","volume":"16","author":"Yu","year":"2017","journal-title":"Mol Med Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"e0207066","DOI":"10.1371\/journal.pone.0207066","article-title":"Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis","volume":"13","author":"Bouachi","year":"2018","journal-title":"PLoS ONE."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e12645","DOI":"10.1111\/sji.12645","article-title":"Interleukin-17A participates in podocyte injury by inducing IL-1\u03b2 secretion through ROS-NLRP3 inflammasome-caspase-1 pathway","volume":"87","author":"Yan","year":"2018","journal-title":"Scand J Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3892\/etm.2020.8698","article-title":"IL-17 aggravates renal injury by promoting podocyte injury in children with primary nephrotic syndrome","volume":"20","author":"Zhai","year":"2020","journal-title":"Exp Ther Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000350161","article-title":"The role of Th17\/IL-17 in the pathogenesis of primary nephrotic syndrome in children","volume":"37","author":"Wang","year":"2013","journal-title":"Kidney Blood Press Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.kint.2018.12.031","article-title":"Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy","volume":"95","author":"Lavoz","year":"2019","journal-title":"Kidney Int."},{"key":"B145","doi-asserted-by":"publisher","first-page":"F505","DOI":"10.1152\/ajprenal.00533.2015","article-title":"Cln 3-requiring 9 is a negative regulator of Th17 pathway-driven inflammation in anti-glomerular basement membrane glomerulonephritis","volume":"311","author":"Lee","year":"2016","journal-title":"Am J Physiol Renal Physiol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"F822","DOI":"10.1152\/ajprenal.00294.2013","article-title":"Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice","volume":"306","author":"Zhang","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2015.10.009","article-title":"Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice","volume":"162","author":"Ramani","year":"2016","journal-title":"Clin Immunol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1189\/jlb.3A0414-184R","article-title":"An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis","volume":"96","author":"Ramani","year":"2014","journal-title":"J Leukoc Biol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"F1391","DOI":"10.1152\/ajprenal.00318.2013","article-title":"Increased tubulointerstitial recruitment of human CD141(hi) CLEC9A(+) and CD1c(+) myeloid dendritic cell subsets in renal fibrosis and chronic kidney disease","volume":"305","author":"Kassianos","year":"2013","journal-title":"Am J Physiol Renal Physiol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013101061","article-title":"CXCL5 drives neutrophil recruitment in TH17-mediated GN","volume":"26","author":"Disteldorf","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4049\/jimmunol.1901463","article-title":"Loss of IL-27R\u03b1 results in enhanced tubulointerstitial fibrosis associated with elevated Th17 responses","volume":"205","author":"Coppock","year":"2020","journal-title":"J Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jacbts.2016.07.009","article-title":"Inhibition of interleukin 17-A but not interleukin-17F signaling lowers blood pressure and reduces end-organ inflammation in angiotensin II-induced hypertension","volume":"1","author":"Saleh","year":"2016","journal-title":"JACC Basic Transl Sci."},{"key":"B153","first-page":"1843","article-title":"miR-125a-3p decreases levels of interlukin-17 and suppresses renal fibrosis via down-regulating TGF-\u03b21 in systemic lupus erythematosus mediated Lupus nephritic mice","volume":"11","author":"Zhang","year":"2019","journal-title":"Am J Transl Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s12026-016-8866-y","article-title":"Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus","volume":"64","author":"He","year":"2016","journal-title":"Immunol Res."},{"key":"B155","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7727\/wimj.2014.008","article-title":"Resveratrol ameliorates diabetes-induced renal damage through regulating the expression of TGF-\u03b21, collagen IV and Th17\/Treg-related cytokines in rats","volume":"63","author":"Wenbin","year":"2014","journal-title":"West Indian Med J."},{"key":"B156","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12882-017-0630-6","article-title":"The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3IL-17 T cells","volume":"18","author":"Wu","year":"2017","journal-title":"BMC Nephrol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1684\/ecn.2016.0373","article-title":"Effect of pro-inflammatory interleukin-17A on epithelial cell phenotype inversion in HK-2 cellsin vitro","volume":"27","author":"Liu","year":"2016","journal-title":"Eur Cytokine Netw."},{"key":"B158","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1159\/000320177","article-title":"Proinflammatory\/profibrotic effects of interleukin-17A on human proximal tubule epithelium","volume":"117","author":"Dudas","year":"2011","journal-title":"Nephron Exp Nephrol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e0183972","DOI":"10.1371\/journal.pone.0183972","article-title":"Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-\u03b21 mediated Smad2\/3 and ERK1\/2 activation","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS ONE."},{"key":"B160","doi-asserted-by":"publisher","first-page":"L487","DOI":"10.1152\/ajplung.00301.2018","article-title":"Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease","volume":"316","author":"Zhang","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cei.13337","article-title":"Interleukin-17 and\u221222 synergy linking inflammation and EMT-dependent fibrosis in Sj\u00f6gren's syndrome","volume":"198","author":"Sisto","year":"2019","journal-title":"Clin Exp Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41374-020-0373-z","article-title":"TGF\u03b21-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sj\u00f6gren's syndrome","volume":"100","author":"Sisto","year":"2020","journal-title":"Lab Invest."},{"key":"B163","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1620\/tjem.240.269","article-title":"Interleukin-17A-induced epithelial-mesenchymal transition of human intrahepatic biliary epithelial cells: implications for primary biliary cirrhosis","volume":"240","author":"Huang","year":"2016","journal-title":"Tohoku J Exp Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5604\/16652681.1198820","article-title":"Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-\u03b22 expression","volume":"15","author":"Zepeda-Morales","year":"2016","journal-title":"Ann Hepatol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"e32009","DOI":"10.1371\/journal.pone.0032009","article-title":"A crosstalk between the Smad and JNK signaling in the TGF-\u03b2-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE."},{"key":"B166","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","article-title":"Combination of IL-17 and TNF\u03b1 induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells","volume":"71","author":"Hot","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B168","doi-asserted-by":"publisher","first-page":"247503","DOI":"10.1155\/2014\/247503","article-title":"Interleukin-17A exacerbates ferric chloride-induced arterial thrombosis in rat carotid artery","volume":"2014","author":"Maione","year":"2014","journal-title":"Int J Inflam."},{"key":"B169","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jid.2017.09.021","article-title":"Protection from psoriasis-related thrombosis after inhibition of IL-23 or IL-17A","volume":"138","author":"Li","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jid.2018.09.021","article-title":"Antagonization of IL-17A attenuates skin inflammation and vascular dysfunction in mouse models of psoriasis","volume":"139","author":"Sch\u00fcler","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.imbio.2012.03.002","article-title":"Increased activity of interleukin-23\/interleukin-17 cytokine axis in primary antiphospholipid syndrome","volume":"218","author":"Popovic-Kuzmanovic","year":"2013","journal-title":"Immunobiology."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/mmr.2012.1055","article-title":"Th1\/Th2\/Th17\/Treg expression in cultured PBMCs with antiphospholipid antibodies","volume":"6","author":"Xiao","year":"2012","journal-title":"Mol Med Rep."},{"key":"B173","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10067-014-2802-0","article-title":"Persistent hypertension in lupus nephritis and the associated risk factors","volume":"34","author":"Shaharir","year":"2015","journal-title":"Clin Rheumatol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1440-1797.2010.01290.x","article-title":"Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis","volume":"15","author":"Ayodele","year":"2010","journal-title":"Nephrology."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3389\/fphar.2019.01015","article-title":"Interleukin 17A participates in renal inflammation associated to experimental and human hypertension","volume":"10","author":"Orejudo","year":"2019","journal-title":"Front Pharmacol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension."},{"key":"B177","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.116.07493","article-title":"Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin ii-induced hypertension","volume":"68","author":"Norlander","year":"2016","journal-title":"Hypertension."},{"key":"B178","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/CS20190682","article-title":"Interleukin-17A induces vascular remodeling of small arteries and blood pressure elevation","volume":"134","author":"Orejudo","year":"2020","journal-title":"Clin Sci."},{"key":"B179","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/cei.12380","article-title":"Pathogenetic role of glomerular CXCL13 expression in lupus nephritis","volume":"178","author":"Worthmann","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"4832543","DOI":"10.1155\/2016\/4832543","article-title":"Association of serum CXCL13 with intrarenal ectopic lymphoid tissue formation in lupus nephritis","volume":"2016","author":"He","year":"2016","journal-title":"J Immunol Res."},{"key":"B181","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10157-014-1060-4","article-title":"Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells","volume":"19","author":"Imaizumi","year":"2015","journal-title":"Clin Exp Nephrol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ki.2011.32","article-title":"The possible role of ChemR23\/Chemerin axis in the recruitment of dendritic cells in lupus nephritis","volume":"79","author":"De Palma","year":"2011","journal-title":"Kidney Int."},{"key":"B183","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1172\/JCI42213","article-title":"The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis","volume":"120","author":"Moreth","year":"2010","journal-title":"J Clin Invest."},{"key":"B184","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1681\/ASN.2010050510","article-title":"Chemokines in renal injury","volume":"22","author":"Chung","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"e58161","DOI":"10.1371\/journal.pone.0058161","article-title":"Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA","volume":"8","author":"Wen","year":"2013","journal-title":"PLoS ONE."},{"key":"B186","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.1038\/s41598-018-26265-z","article-title":"Mesenchymal stem cells and T cells in the formation of tertiary lymphoid structures in lupus nephritis","volume":"8","author":"Dorraji","year":"2018","journal-title":"Sci Rep."},{"key":"B187","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ajpath.2020.07.015","article-title":"Kidney tertiary lymphoid structures in lupus nephritis develop into large interconnected networks and resemble lymph nodes in gene signature","volume":"190","author":"Dorraji","year":"2020","journal-title":"Am J Pathol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.1600281","article-title":"BAFF induces tertiary lymphoid structures and positions T cells within the glomeruli during lupus nephritis","volume":"198","author":"Kang","year":"2017","journal-title":"J Immunol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7150\/thno.48624","article-title":"Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics."},{"key":"B190","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/cei.12287","article-title":"Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane","volume":"176","author":"Summers","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.ki.5002082","article-title":"Role of mesothelial cell-derived granulocyte colony-stimulating factor in interleukin-17-induced neutrophil accumulation in the peritoneum","volume":"71","author":"Witowski","year":"2007","journal-title":"Kidney Int."},{"key":"B192","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.exphem.2010.06.004","article-title":"IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement","volume":"38","author":"Liu","year":"2010","journal-title":"Exp Hematol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.ajpath.2014.01.023","article-title":"Innate IL-17A-producing leukocytes promote acute kidney injury via inflammasome and Toll-like receptor activation","volume":"184","author":"Chan","year":"2014","journal-title":"Am J Pathol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.4049\/jimmunol.0901942","article-title":"IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2\/monocyte chemoattractant protein-1 induction","volume":"184","author":"Shahrara","year":"2010","journal-title":"J Immunol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.4049\/jimmunol.1300479","article-title":"IL-17RA is essential for optimal localization of follicular Th cells in the germinal center light zone to promote autoantibody-producing B cells","volume":"191","author":"Ding","year":"2013","journal-title":"J Immunol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41590-019-0367-4","article-title":"IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival","volume":"20","author":"Majumder","year":"2019","journal-title":"Nat Immunol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41423-020-00540-4","article-title":"IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis","volume":"18","author":"Ma","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin Immunol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum Immunol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/ndt\/gfy370","article-title":"Transcriptional modulation of the T helper 17\/interleukin 17 axis ameliorates renal ischemia-reperfusion injury","volume":"34","author":"Lee","year":"2019","journal-title":"Nephrol Dial Transplant."},{"key":"B201","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/00365513.2011.652158","article-title":"Imbalance of regulatory T cells to Th17 cells in IgA nephropathy","volume":"72","author":"Lin","year":"2012","journal-title":"Scand J Clin Lab Invest."},{"key":"B202","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1038\/s41598-019-38811-4","article-title":"Interleukin 17A promotes diabetic kidney injury","volume":"9","author":"Ma","year":"2019","journal-title":"Sci Rep."},{"key":"B203","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ndt\/gfw397","article-title":"IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy","volume":"33","author":"Kuo","year":"2018","journal-title":"Nephrol Dial Transplant."},{"key":"B204","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/ki.2015.200","article-title":"Th-17 cell activation in response to high salt following acute kidney injury is associated with progressive fibrosis and attenuated by AT-1R antagonism","volume":"88","author":"Mehrotra","year":"2015","journal-title":"Kidney Int."},{"key":"B205","doi-asserted-by":"publisher","first-page":"766","DOI":"10.4314\/ahs.v16i3.17","article-title":"Association of interleukin 17\/angiotensin II with refractory hypertension risk in hemodialysis patients","volume":"16","author":"Wang","year":"2016","journal-title":"Afr Health Sci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/ki.2008.394","article-title":"Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction","volume":"74","author":"Dong","year":"2008","journal-title":"Kidney Int."},{"key":"B207","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/CIRCRESAHA.113.301934","article-title":"Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A","volume":"113","author":"Ge","year":"2013","journal-title":"Circ Res."},{"key":"B208","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1159\/000343571","article-title":"Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease","volume":"36","author":"Kim","year":"2012","journal-title":"Am J Nephrol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.molmed.2020.09.009","article-title":"Leveraging heterogeneity in systemic lupus erythematosus for new therapies","volume":"27","author":"Allen","year":"2021","journal-title":"Trends Mol Med."},{"key":"B210","doi-asserted-by":"publisher","first-page":"16581","DOI":"10.1038\/s41598-019-53017-4","article-title":"Risk of end-stage renal disease in psoriatic patients: real-world data from a nationwide population-based cohort study","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep."},{"key":"B211","doi-asserted-by":"publisher","first-page":"f5961","DOI":"10.1136\/bmj.f5961","article-title":"Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study","volume":"347","author":"Wan","year":"2013","journal-title":"BMJ."},{"key":"B212","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","article-title":"Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study","volume":"78","author":"Chi","year":"2015","journal-title":"J Dermatol Sci."},{"key":"B213","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s10067-017-3804-5","article-title":"Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals","volume":"36","author":"Mori","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/acr.22713","article-title":"Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study","volume":"68","author":"Couderc","year":"2016","journal-title":"Arthritis Care Res."},{"key":"B215","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/acr.22176","article-title":"Estimating the occurrence of renal complications among persons with ankylosing spondylitis","volume":"66","author":"Levy","year":"2014","journal-title":"Arthritis Care Res."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3389\/fphar.2019.01073","article-title":"Spondyloarthritis patients suffer increased risk of renal complications compared with general population: a retrospective observational study","volume":"10","author":"Xiao","year":"2019","journal-title":"Front Pharmacol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12882-019-1658-6","article-title":"Gender and chronic kidney disease in ankylosing spondylitis: a single-center retrospectively study","volume":"20","author":"Ye","year":"2019","journal-title":"BMC Nephrol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.4049\/jimmunol.1801042","article-title":"IL-17 in renal immunity and autoimmunity","volume":"201","author":"Biswas","year":"2018","journal-title":"J Immunol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ki.2014.33","article-title":"IL-17A is a novel player in dialysis-induced peritoneal damage","volume":"86","author":"Rodrigues-D\u00edez","year":"2014","journal-title":"Kidney Int."},{"key":"B220","first-page":"14","article-title":"Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis","volume":"34","author":"Lei","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3389\/fimmu.2017.01195","article-title":"Immunity and fibrogenesis: the role of Th17\/IL-17 axis in HBV and HCV-induced chronic hepatitis and progression to cirrhosis","volume":"8","author":"Paquissi","year":"2017","journal-title":"Front Immunol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fmed.2017.00126","article-title":"The role of cytokines in the fibrotic responses in crohn's disease","volume":"4","author":"Curciarello","year":"2017","journal-title":"Front Med."},{"key":"B223","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1007\/s10620-018-5234-x","article-title":"IL-17A promotes initiation and development of intestinal fibrosis through EMT","volume":"63","author":"Zhang","year":"2018","journal-title":"Dig Dis Sci."},{"key":"B224","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1164\/rccm.201102-0236OC","article-title":"The Th17 pathway in cystic fibrosis lung disease","volume":"184","author":"Tan","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B225","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B226","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.kint.2015.12.005","article-title":"The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis","volume":"89","author":"Ferrantelli","year":"2016","journal-title":"Kidney Int."},{"key":"B227","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12890-015-0012-4","article-title":"IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation","volume":"15","author":"Dong","year":"2015","journal-title":"BMC Pulm Med."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/mmr.2016.5392","article-title":"Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17\/Treg cell balance","volume":"14","author":"Gu","year":"2016","journal-title":"Mol Med Rep."},{"key":"B229","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat Immunol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000453059","article-title":"Interleukin-17RA promotes humoral responses and glomerular injury in experimental rapidly progressive glomerulonephritis","volume":"135","author":"Ghali","year":"2017","journal-title":"Nephron."},{"key":"B231","doi-asserted-by":"publisher","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B232","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/path.5438","article-title":"Control of neutrophil influx during peritonitis by transcriptional cross-regulation of chemokine CXCL1 by IL-17 and IFN-\u03b3","volume":"251","author":"Catar","year":"2020","journal-title":"J Pathol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.4049\/jimmunol.1200385","article-title":"IL-17 and TNF-\u03b1 sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation","volume":"188","author":"Griffin","year":"2012","journal-title":"J Immunol."},{"key":"B234","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.4049\/jimmunol.0903162","article-title":"IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation","volume":"184","author":"Roussel","year":"2010","journal-title":"J Immunol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4049\/jimmunol.1203315","article-title":"HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization","volume":"191","author":"Herjan","year":"2013","journal-title":"J Immunol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/ni.2081","article-title":"Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)","volume":"12","author":"Sun","year":"2011","journal-title":"Nat Immunol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Transl Med."},{"key":"B238","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/1756-185X.12636","article-title":"Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients","volume":"18","author":"Biswas","year":"2015","journal-title":"Int J Rheum Dis."},{"key":"B239","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/ar4499","article-title":"T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?","volume":"16","author":"Brkic","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"B240","doi-asserted-by":"publisher","first-page":"20651","DOI":"10.1038\/srep20651","article-title":"A pathogenic IFN\u03b1, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients","volume":"6","author":"L\u00f3pez","year":"2016","journal-title":"Sci Rep."},{"key":"B241","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","article-title":"Effects of interleukin 17 on the cardiovascular system","volume":"16","author":"Robert","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B242","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/acr.22751","article-title":"Burden of comorbidity in systemic lupus erythematosus in the UK, 1999-2012","volume":"68","author":"Rees","year":"2016","journal-title":"Arthritis Care Res."},{"key":"B243","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3324\/haematol.2018.209536","article-title":"Interleukin-17\/Interleukin-21 and interferon-\u03b3 producing T cells specific for \u03b22 glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome","volume":"104","author":"Benagiano","year":"2019","journal-title":"Haematologica."},{"key":"B244","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.4049\/jimmunol.1001879","article-title":"IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice","volume":"185","author":"Chen","year":"2010","journal-title":"J Immunol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fimmu.2016.00057","article-title":"The role of IL-17 and TH17 cells in the bone catabolic activity of PTH","volume":"7","author":"Pacifici","year":"2016","journal-title":"Front Immunol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N Engl J Med."},{"key":"B247","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1136\/annrheumdis-2017-212127","article-title":"Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation","volume":"77","author":"Glatt","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B248","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N Engl J Med."},{"key":"B249","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1177\/0961203318762598","article-title":"A case of refractory lupus nephritis complicated by psoriasis vulgaris that was controlled with secukinumab","volume":"27","author":"Satoh","year":"2018","journal-title":"Lupus."},{"key":"B250","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","article-title":"Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study","volume":"392","author":"van Vollenhoven","year":"2018","journal-title":"Lancet."},{"key":"B251","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4049\/jimmunol.1700418","article-title":"IL-23 limits the production of IL-2 and promotes autoimmunity in lupus","volume":"199","author":"Dai","year":"2017","journal-title":"J Immunol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.clim.2015.04.004","article-title":"Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL\/lpr mice","volume":"158","author":"Edwards","year":"2015","journal-title":"Clin Immunol."},{"key":"B253","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/art.39155","article-title":"CD147\/basigin limits lupus nephritis and Th17 cell differentiation in mice by inhibiting the interleukin-6\/STAT-3 pathway","volume":"67","author":"Maeda","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13075-016-1034-x","article-title":"JAK3-STAT pathway blocking benefits in experimental lupus nephritis","volume":"18","author":"Ripoll","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B255","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/1756-185X.13743","article-title":"\u03b1-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation","volume":"23","author":"Zhou","year":"2020","journal-title":"Int J Rheum Dis."},{"key":"B256","doi-asserted-by":"publisher","first-page":"2431617","DOI":"10.1155\/2019\/2431617","article-title":"3-acetyloxy-oleanolic acid attenuates pristane-induced lupus nephritis by regulating Th17 differentiation","volume":"2019","author":"Zhou","year":"2019","journal-title":"J Immunol Res."},{"key":"B257","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4049\/jimmunol.1501537","article-title":"Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus","volume":"196","author":"Yin","year":"2016","journal-title":"J Immunol."},{"key":"B258","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4049\/immunohorizons.2000033","article-title":"Efficacy of the combination of metformin and CTLA4Ig in the (NZB \u00d7 NZW)F1 mouse model of lupus nephritis","volume":"4","author":"Cornaby","year":"2020","journal-title":"Immunohorizons."},{"key":"B259","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fimmu.2019.00833","article-title":"Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2665-9913(20)30004-7","article-title":"Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Sun","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12865-019-0305-0","article-title":"Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17\/Treg cells in refractory SLE patients","volume":"20","author":"Zhao","year":"2019","journal-title":"BMC Immunol."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1177\/0961203319877239","article-title":"Restoring T-helper 17 cell\/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus","volume":"28","author":"Chu","year":"2019","journal-title":"Lupus."},{"key":"B263","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet."},{"key":"B264","doi-asserted-by":"publisher","first-page":"106891","DOI":"10.1016\/j.intimp.2020.106891","article-title":"MicroRNA-10a-3p mediates Th17\/Treg cell balance and improves renal injury by inhibiting REG3A in lupus nephritis","volume":"88","author":"You","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.3390\/ijms21144975","article-title":"Punicalagin ameliorates lupus nephritis via inhibition of PAR2","volume":"21","author":"Seo","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B266","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11418-015-0900-1","article-title":"Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL\/lpr mice by inhibiting expression of Ca(2+)\/calmodulin-dependent protein kinase-4","volume":"69","author":"Shui","year":"2015","journal-title":"J Nat Med."},{"key":"B267","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3899\/jrheum.170737","article-title":"Hydroxychloroquine inhibits the differentiation of Th17 cells in systemic lupus erythematosus","volume":"45","author":"Yang","year":"2018","journal-title":"J Rheumatol."},{"key":"B268","doi-asserted-by":"publisher","first-page":"766","DOI":"10.6061\/clinics\/2013(06)07","article-title":"Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"68","author":"Silva JC","year":"2013","journal-title":"Clinics."},{"key":"B269","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ki.2010.84","article-title":"Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production","volume":"78","author":"von Vietinghoff","year":"2010","journal-title":"Kidney Int."},{"key":"B270","doi-asserted-by":"publisher","first-page":"e124575","DOI":"10.1172\/jci.insight.124575","article-title":"Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients","volume":"4","author":"Slight-Webb","year":"2019","journal-title":"JCI Insight."},{"key":"B271","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med."},{"key":"B272","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1177\/0961203318797425","article-title":"Belimumab restores Treg\/Th17 balance in patients with refractory systemic lupus erythematosus","volume":"27","author":"Prete","year":"2018","journal-title":"Lupus."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.654912\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T08:54:04Z","timestamp":1630745644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.654912\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":272,"alternative-id":["10.3389\/fmed.2021.654912"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.654912","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"article-number":"654912"}}